Occam Crest Management LP

DARIEN, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$180.0M2026 Q3+ $7.6M options (notional, not included)
Positions27
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.71.5%

Occam Crest Management LP reported 27 positions worth $180.0M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PGEN (12.4%). Biggest move: reduce PGEN ($7.6M).

10 / 27 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PGENPrecigen$23.3M12.42%2,721,521——-47.0%
▸ 2 TGTXTG Therapeutics$21.0M11.22%377,229——+15.7%
▸ 3 SANMSanmina$17.0M9.05%79,000——-28.4%
▸ 4 FTAIFTAI Aviation$15.2M8.11%91,000——+1.7%
▸ 5 FOURShift4 Payments$11.6M6.18%320,345——+17.4%
▸ 6 CMPSCOMPASS Pathways$11.0M5.86%883,200——-33.5%
▸ 7 NESRNational Energy Services$10.4M5.57%410,053——-20.6%
▸ 8 TWLOTwilio$8.8M4.68%30,000——-31.8%
▸ 9 MGNIMagnite$8.2M4.39%325,840——+14.0%
▸ 10 NVCTNuvectis Pharma$7.5M4.02%357,147——-12.5%

Pro Feature

The remaining 17 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Occam Crest Management LP hold as of Q3 2026?

Occam Crest Management LP reported 27 positions worth $180.0M in its Q3 2026 13F filing. Largest positions: PGEN (12.4%), TGTX (11.2%), SANM (9.1%), FTAI (8.1%) and FOUR (6.2%).

What did Occam Crest Management LP buy in Q3 2026?

New positions: DOCS, CABA and TTMI. Added to: FOUR, MGNI, FTAI, CMPS and ISHARES TR (8 in all).

What did Occam Crest Management LP sell in Q3 2026?

Reduced: PGEN, NESR, EVER, TGTX and NUVECTIS PHARMA INC (9 in all). Sold out entirely: BMNR, PRECIGEN INC, BLDR, ISHARES TR and IWF (9 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.